Results 31 to 40 of about 12,152 (205)
FACETS, 2020 In 2017, mifepristone and misoprostol became available for early pregnancy termination as the combination pack Mifegymiso® in Ottawa, Ontario, Canada.
Kathryn J. LaRoche +2 more
doaj +1 more source
Pakistan Journal of Pharmaceutical Sciences, 2022 To assess the clinical efficacy of mifepristone complicated with anemia and its effect on the hemoglobin, red blood cell, as well as hematocrit. Sixty patients with hysteromyoma complicated with anemia between December 2018 and December 2020 were ...
Renli Ye, China
doaj +1 more source
Advances in the management of uterine fibroids [PDF]
, 2009 Uterine fibroids are extremely common, with major surgery the current main management option; uterine artery embolisation is an alternative, but risks to fertility are unclear.
Munro, Kirsty I, Critchley, Hilary Od
core +1 more source
Mifepristone binding site interactions. [PDF]
, 2013 ancSR2 is shown in slate blue; mifepristone is shown in magenta (oxygens, red; nitrogens, blue). Residues within 4.2 Å of the ligand are shown. A. Site-one mifepristone interacts with both the monomer in the asymmetric unit as well as residues in a ...
Jennifer K. Colucci (119487) +1 more
core +1 more source
Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking [PDF]
, 2011 Chronic ethanol exposure leads to dysregulation of the hypothalamic-pituitary-adrenal axis, leading to changes in glucocorticoid release and function that have been proposed to maintain pathological alcohol consumption and increase vulnerability to ...
Simms, Jeffrey A +9 more
core +1 more source
Mifepristone: A potential postcoital contraceptive [PDF]
, 2001 Mifepristone is an orally-active progesterone receptor antagonist. When a single dose of mifepristone is given in the mid- or late follicular phase, it may diminish or inhibit the luteinising hormone (LH) surge.
Ho, PC
core +1 more source
Mifepristone: Contraceptive and non-contraceptive uses [PDF]
, 2002 Mifepristone is an orally active progesterone antagonist. It can be used for both contraceptive and non-contraceptive clinical indications. It is a very effective drug for emergency contraception with a low incidence of side effects. There is a potential
Pak, CH, Oi, ST, Ng, EHY
core +1 more source
Fly, 2022 Mifepristone increases life span in female Drosophila melanogaster, and its molecular target(s) remain unclear. Here small molecule and genetic interventions were tested for ability to mimic mifepristone, or to decrease life span in a way that can be ...
Gary N. Landis +6 more
doaj +1 more source
Gynecological Endocrinology, 2023 Objective This study is aimed to determine the efficacy of a cocktail style treatment by combining GnRH-antagonist, letrozole, and mifepristone on the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women.Methods This prospective ...
Qianrong Qi +4 more
doaj +1 more source